JPA Health

JPA Health is a health-only integrated agency founded in 2007 by Carrie Jones. Its communications, medical, marketing, advocacy and data capabilities serve organizations across the product lifecycle, from scientific education and investor narratives to patient engagement and public-health campaigns.

The firm is positioned between a healthcare PR specialist and a broader medical communications group. Recent acquisitions expanded scientific, medical and European delivery while retaining a focused healthcare identity.

JPA combines public relations, marketing, medical communications, public affairs, advocacy, investor relations, scientific services, market access and data-led research. This supports connected programs for professional, patient, policy and capital-market audiences.

Pharmaceutical, biotechnology, medical-device, public-health and patient-advocacy work is central to the agency. The team’s health-only model is particularly relevant where scientific accuracy and stakeholder-specific communications are non-negotiable.

Washington anchors policy and advocacy work, with Boston, Cambridge and Philadelphia adding life-sciences depth. London and Switzerland extend the network into European medical and corporate communications.

The digital footprint is anchored by a current corporate site with accessible capability, leadership and case information.

The human editorial assessment found a consistent public profile across the agency site and independent organizational or trade evidence, without overstating sentiment.

Med Ad News named JPA Health its 2025 Med Comms Agency of the Year. PharmaLive’s coverage of the official Manny Awards result confirms the recognition and the industry-led judging structure.

The agency’s service architecture reflects contemporary digital production and measurement, while named tools or platforms remain bounded to what the public site documents.

JPA’s differentiator is the integration of medical communications and scientific services with corporate PR, advocacy and marketing. That structure can reduce fragmentation across evidence, reputation and commercialization work.

Compared with general health PR firms, JPA offers greater scientific and medical depth. Compared with large healthcare networks, it presents a more concentrated independent agency with senior founder leadership.